UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Get guidance on which passive funds to buy for retirement, focusing on cost, diversification, and long-term goals.
24,385 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
A major AI cloud deal sparked a notable move in CoreWeave stock on Wednesday. This article explains what happened, wh...
A revised look at 2026 shows silver facing both potential gains and headwinds. This article weighs the catalysts for ...
Biotech stocks surged after news that a polarizing FDA official is stepping down. The rally centers on this biotech’s...
Six sectors are signaling strong hiring for today’s graduates. A new market analysis highlights healthcare, software,...
As oil prices surge toward triple digits, Trump volleyed calls for immediate rate cuts from Powell. The Fed appears p...
Investors often ask where will XRP's price be by 2030. This piece breaks down the key drivers, real-world adoption, a...
Investors are watching nextnav (nn) 2025 earnings to see if the company can turn its positioning tech into steady pro...
When oil prices spike, the market story often shifts. This piece uses prices skyrocketing years history to explore wh...
Airports face ongoing delays as spring travel returns. Enrolling in TSA PreCheck may help speed security lines for ti...
Bitcoin has fallen about 19% this year, prompting a closer look at three ETF types—spot, futures, and leveraged futur...
Microsoft steps into a Texas data center project abandoned by OpenAI, reshaping AI infrastructure near Abilene as the...